Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04508933

Comparison of Extra Vascular Lung Water Index in Covid-19 ARDS and "Typical"ARDS Patients

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
Istanbul University - Cerrahpasa · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Covid-19 also primarily affects endothelium that line up the alveoli. The resulting hypoxemia may differ from "typical" Acute Respiratory Distress Syndrome (ARDS) due to maldistribution of perfusion related to the ventilation. Thus, pathophysiology of Covid-19 ARDS is different, which requires different interventions than typical ARDS. The investigators will assess whether extravascular lung water index and permeability of the alveolar capillary differs from typical ARDS with transpulmonary thermodilution (TPTD) technique. Extravascular Lung Water Index (EVLWI) and Pulmonary Vascular Permeability Index (PVPI) will be compared.

Conditions

Interventions

TypeNameDescription
DEVICEExtravascular Lung Water IndexMeasurement of the EVLWI
DEVICEPulmonary Vascular Permeability IndexMeasurement of the PVPI

Timeline

Start date
2020-09-01
Primary completion
2020-09-30
Completion
2020-12-31
First posted
2020-08-11
Last updated
2021-10-26

Locations

1 site across 1 country: Turkey (Türkiye)

Regulatory

Source: ClinicalTrials.gov record NCT04508933. Inclusion in this directory is not an endorsement.